0000899243-19-027114.txt : 20191112 0000899243-19-027114.hdr.sgml : 20191112 20191112161524 ACCESSION NUMBER: 0000899243-19-027114 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20191112 FILED AS OF DATE: 20191112 DATE AS OF CHANGE: 20191112 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Beardsley Robert A CENTRAL INDEX KEY: 0001310845 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-39114 FILM NUMBER: 191209590 MAIL ADDRESS: STREET 1: 6935 WATERMAN AVENUE CITY: UNIVERSITY CITY STATE: MO ZIP: 63130 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: Galera Therapeutics, Inc. CENTRAL INDEX KEY: 0001563577 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 461454898 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 101 LINDENWOOD DRIVE STREET 2: SUITE 405 CITY: MALVERN STATE: PA ZIP: 19355 BUSINESS PHONE: 610-725-1500 MAIL ADDRESS: STREET 1: 101 LINDENWOOD DRIVE STREET 2: SUITE 405 CITY: MALVERN STATE: PA ZIP: 19355 4 1 doc4.xml FORM 4 SUBMISSION X0306 4 2019-11-12 0 0001563577 Galera Therapeutics, Inc. GRTX 0001310845 Beardsley Robert A C/O GALERA THERAPEUTICS, INC., 2 W LIBERTY BLVD #100 MALVERN PA 19355 0 1 0 0 Chief Operating Officer Common Stock 2019-11-12 4 C 0 15361 A 68191 D Series A Preferred Stock 2019-11-12 4 C 0 68907 D Common Stock 13627 0 D Series B Preferred Stock 2019-11-12 4 C 0 2000 D Common Stock 395 0 D Series C Preferred Stock 2019-11-12 4 C 0 6774 D Common Stock 1339 0 D Upon the closing of the Issuer's initial public offering, each share of preferred stock automatically converted into shares of the Issuer's common stock on a 0.197763-for-one basis. /s/ J. Mel Sorensen, Attorney-in-Fact 2019-11-12